Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy Plus Adjuvant Interferon Alpha-2b in Melanoma
NCT00003444Phase 3Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Mar 1999
- Primary completion
- Sep 2003
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 3, randomised trial of interferon alfa-2b in melanoma (2 arms), sponsored by Eastern Cooperative Oncology Group. Primary endpoints: Regional Relapse, Relapse-Free Survival and 2 more. Started Mar 1999; status: completed.
02
Drugs
interferon alfa-2b
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00003444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003444.